COVID-19 Vaccines

National advice and considerations on the use of this vaccine in patients taking immunosuppressive medicines
Advice on reporting suspected side effects to COVID-19 vaccines. Also correct mechanisms for reporting suspected defective products and counterfeit products.
Advice on using COVID-19 vaccines in individuals with acute severe febrile illness
Information on use of the vaccine in patients who are receiving anticoagulants or have a bleeding disorder is given below.
Advice on post-vaccination observation requirements in all settings
The Pfizer-BioNTech COVID-19 vaccine must be defrosted before use. This page gives guidance on considerations whilst thawing the vaccine.
Information on batch specific dosing and withdrawing an additional dose from an individual vial is given.
Specific information for Pfizer-BioNTech and signposting to general guidance on contraindications and cautions information common to all COVID-19 vaccines
Advice on post-vaccination observation requirements in all delivery settings
Information on batch specific dosing and withdrawing an additional dose from an individual vaccine vial is given.
Information on intervals between dosing and completion of the vaccination schedule with an alternative brand of vaccine is given.
Formulation information such as latex content, diluent, sodium content and stability, is provided for AstraZeneca COVID-19 Vaccine.